Showing results (511-520 of 539) with videos related to
Sort By:
Pageof 54
European Journal of Nuclear Medicine and Molecular Imaging|August 22, 2020
Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot studyY Touchefeu, C Bailly, E Frampas, et al.Endocrinology|July 21, 2007
Role and regulation of the serum- and glucocorticoid-regulated kinase 1 in fertile and infertile human endometriumFakhera Feroze-Zaidi, Luca Fusi, Masashi Takano, et al.Autophagy Reports|April 17, 2023
Upregulation of the ESCRT pathway and multivesicular bodies accelerates degradation of proteins associated with neurodegenerationRon Benyair, Sai Srinivas Panapakkam Giridharan, Pilar Rivero-Ríos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2017
Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal CancerEfrat Dotan, Steven J Cohen, Alexander N Starodub, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 9, 2003
Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?Robert M Sharkey, Arnold Brenner, Jack Burton, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2-Negative Breast CancerCaroline Rousseau, David M Goldenberg, Mathilde Colombié, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 30, 2012
Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvementPierre-Yves Salaun, Loïc Campion, Claire Bournaud, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2017
Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab GovitecanRebecca Suk Heist, Michael J Guarino, Gregory Masters, et al.Biorxiv : the Preprint Server for Biology|July 18, 2023
Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrilsAlec A Desai, Jennifer M Zupancic, Hanna Trzeciakiewicz, et al.The New England Journal of Medicine|February 21, 2019
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast CancerAditya Bardia, Ingrid A Mayer, Linda T Vahdat, et al.Pageof 54